Cargando…

Ten interleukins and risk of prostate cancer

BACKGROUND: Interleukins (ILs) have been reported to be related to prostate cancer. The aims of this study were to estimate the levels for several key interleukins in prostate cancer and the causal effects between them. METHODS: We conducted a bi-directional two-sample Mendelian randomization (MR) s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Bing-Hui, Yan, Si-Yu, Luo, Li-Sha, Zeng, Xian-Tao, Wang, Yong-Bo, Wang, Xing-Huan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887118/ https://www.ncbi.nlm.nih.gov/pubmed/36733309 http://dx.doi.org/10.3389/fonc.2023.1108633

Ejemplares similares

Causal relationship between obesity, lifestyle factors and risk of benign prostatic hyperplasia: a univariable and multivariable Mendelian randomization study
por: Wang, Yong-Bo, et al.
Publicado: (2022)

Knowledge of and Compliance With Guidelines in the Management of Non-Muscle-Invasive Bladder Cancer: A Survey of Chinese Urologists
por: Wang, Dan-Qi, et al.
Publicado: (2021)

Combination Therapy of Prostate Cancer by Oncolytic Adenovirus Harboring Interleukin 24 and Ionizing Radiation
por: Mao, Li-jun, et al.
Publicado: (2020)

Prognostic Implications of Novel Ten-Gene Signature in Uveal Melanoma
por: Luo, Huan, et al.
Publicado: (2020)

Combination of Intravesical Bacille Calmette-Guérin and Chemotherapy vs. Bacille Calmette-Guérin Alone in Non-muscle Invasive Bladder Cancer: A Meta-Analysis
por: Huang, Di, et al.
Publicado: (2019)

Role of Interleukin-1 family in bone metastasis of prostate cancer
por: Tong, Yuanhao, et al.
Publicado: (2022)

Comparison on the Efficacy and Safety of Different Surgical Treatments for Benign Prostatic Hyperplasia With Volume >60 mL: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Controlled Trials
por: Wang, Yong-Bo, et al.
Publicado: (2021)

Case Report: A novel intergenic MIR4299/MIR8070-RET fusion with RET amplification and clinical response to pralsetinib in a lung adenocarcinoma patient
por: Wang, Sha-Sha, et al.
Publicado: (2022)

Corrigendum: Case report: A novel intergenic MIR4299/MIR8070-RET fusion with RET amplification and clinical response to pralsetinib in a lung adenocarcinoma patient
por: Wang, Sha-Sha, et al.
Publicado: (2022)

Detection rate of fluorine-18 prostate-specific membrane antigen-1007 PET/CT for prostate cancer in primary staging and biochemical recurrence with different serum PSA levels: A systematic review and meta-analysis
por: Liu, Xue, et al.
Publicado: (2022)

Benign or Malignant? Two Case Reports of Gigantic Prostatic Cyst
por: Yu, Jiang, et al.
Publicado: (2016)

Intake of Non-steroidal Anti-inflammatory Drugs and the Risk of Prostate Cancer: A Meta-Analysis
por: Shang, Zhenhua, et al.
Publicado: (2018)

Application Value of Radiomic Nomogram in the Differential Diagnosis of Prostate Cancer and Hyperplasia
por: Gui, Shaogao, et al.
Publicado: (2022)

Ten-Year Single Institutional Analysis of Geographic and Demographic Characteristics of Patients Treated With Stereotactic Body Radiation Therapy for Localized Prostate Cancer
por: Aghdam, Nima, et al.
Publicado: (2021)

Clinical target volume and organs at risk segmentation for rectal cancer radiotherapy using the Flex U-Net network
por: Sha, Xue, et al.
Publicado: (2023)

Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac
por: Gao, Lin-Rui, et al.
Publicado: (2023)

Ten‐step method of high‐dose LDR (125)I brachytherapy for intermediate‐risk prostate cancer
por: Okamoto, Keisei
Publicado: (2021)

A Ten-N(6)-Methyladenosine (m(6)A)-Modified Gene Signature Based on a Risk Score System Predicts Patient Prognosis in Rectum Adenocarcinoma
por: Huang, Wei, et al.
Publicado: (2021)

Prognostic Value of a Ten-Gene Signature in HNSCC Patients Based on Tumor-Associated Macrophages Expression Profiling
por: Lu, Zhaoyi, et al.
Publicado: (2020)

Population-Based Comparison of Different Risk Stratification Systems Among Prostate Cancer Patients
por: Xie, Mu, et al.
Publicado: (2021)

Radiomics of Multiparametric MRI to Predict Biochemical Recurrence of Localized Prostate Cancer After Radiation Therapy
por: Zhong, Qiu-Zi, et al.
Publicado: (2020)

Radiotherapy plus immune checkpoint inhibitor in prostate cancer
por: Li, Tianjie, et al.
Publicado: (2023)

OSbrca: A Web Server for Breast Cancer Prognostic Biomarker Investigation With Massive Data From Tens of Cohorts
por: Yan, Zhongyi, et al.
Publicado: (2019)

The Landscape of Immune Cells Infiltrating in Prostate Cancer
por: Wu, Zhicong, et al.
Publicado: (2020)

A novel hydrogel orthotopic injection model in moderately hypofractionated radiation therapy for prostate cancer: Adaptive degradation and durable imaging
por: Yu, Hao, et al.
Publicado: (2023)

Identification of Ten Core Hub Genes as Potential Biomarkers and Treatment Target for Hepatoblastoma
por: Sun, Rui, et al.
Publicado: (2021)

Serum Metabolic Profiling Identifies a Biomarker Panel for Improvement of Prostate Cancer Diagnosis
por: Xu, Huan, et al.
Publicado: (2021)

Clinical characteristics and prostate-cancer-specific mortality of competitive risk nomogram in the second primary prostate cancer
por: Xu, Chaojie, et al.
Publicado: (2023)

Development of a novel nomogram for predicting clinically significant prostate cancer with the prostate health index and multiparametric MRI
por: Mo, Li-Cai, et al.
Publicado: (2022)

Prostate Microbiota and Prostate Cancer: A New Trend in Treatment
por: Che, Bangwei, et al.
Publicado: (2021)

Erectile function, urinary continence and oncologic outcomes of neurovascular bundle sparing robot-assisted radical prostatectomy for high-risk prostate cancer: A systematic review and meta-analysis
por: Liu, Yang, et al.
Publicado: (2023)

IVIM Parameters on MRI Could Predict ISUP Risk Groups of Prostate Cancers on Radical Prostatectomy
por: Chang, Chun-Bi, et al.
Publicado: (2021)

Transcriptional Control of Metastasis by Integrated Stress Response Signaling
por: Lu, Si, et al.
Publicado: (2021)

The roles and clinical applications of interleukins in endometrial carcinoma
por: Zang, Yuqin, et al.
Publicado: (2022)

Ten-Year Outcomes of Percutaneous Radiofrequency Ablation for Colorectal Cancer Liver Metastases in Perivascular vs. Non-Perivascular Locations: A Propensity-Score Matched Study
por: Jiang, Binbin, et al.
Publicado: (2020)

Intra-Individual Comparison of 18F-PSMA-1007 and 18F-FDG PET/CT in the Evaluation of Patients With Prostate Cancer
por: Zhou, Xing, et al.
Publicado: (2021)

COVID-19: Presumed Infection Routes and Psychological Impact on Staff in Administrative and Logistics Departments in a Designated Hospital in Wuhan, China
por: Luo, Li-Sha, et al.
Publicado: (2020)

Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potential Immunotherapy for Prostate Cancer
por: Esteves, Ana M., et al.
Publicado: (2021)

Survival Outcomes of Radical Prostatectomy + Extended Pelvic Lymph Node Dissection and Radiotherapy in Prostate Cancer Patients With a Risk of Lymph Node Invasion Over 5%: A Population-Based Analysis
por: Chen, Junru, et al.
Publicado: (2020)

Causal Association Between Periodontitis and Type 2 Diabetes: A Bidirectional Two-Sample Mendelian Randomization Analysis
por: Wang, Yong-Bo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_07pbqj9vffp1509ipvp4a9pdc2